Compound ID | 916
Class: Thiazolyl peptide
| Spectrum of activity: | Gram-negative |
| Details of activity: | Effective against multiple drug resistant Enterococcus faecium |
| Description: | Ueda Y, Pucci MJ, Barrett JF, et al. In vitro antibacterial activity, mechanism of action, and resistance development of nocathiacins, new class of thiazolyl peptide antibiotics. 43rd-ICAAC 2003;260 |
| Institute where first reported: | Bristol-Myers Squibb, UK |
| Year first mentioned: | 2003 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.48.10.3697-3701.2004 |